David Ross Parkinson serves as Executive at FACET BIOTECH CORP, where they oversee executive responsibilities. Since joining the company, David Ross Parkinson has executed 11 insider transactions totaling $94.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 9, 2025 involved selling 65,675 shares valued at $0.
David Ross Parkinson currently holds 65,675 shares of FACET BIOTECH CORP (FACT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Ross Parkinson has been a net buyer of FACT stock. They have purchased $94.7K and sold $0 worth of shares.
David Ross Parkinson's most recent insider trade was on Oct 9, 2025, when they sold 65,675 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.30 |
| Discretionary |
| Dec 30, 2022 | EPIX | $8.0K | Purchase | 3,067 | $2.60 | Discretionary |
| Dec 22, 2022 | EPIX | $51.1K | Purchase | 21,367 | $2.39 | Discretionary |
| Jun 30, 2022 | EPIX | $14.5K | Purchase | 4,887 | $2.96 | Discretionary |
| Jan 3, 2017 | CERU | $12.5K | Award | 16,234 | $0.77 | Discretionary |
| Oct 3, 2016 | CERU | $12.5K | Award | 12,254 | $1.02 | Discretionary |
| Apr 21, 2010 | FACT | $67.5K | Disposition | 2,500 | $27.00 | Discretionary |
| Apr 20, 2010 | FACT | $225.0K | Tender | 8,333 | $27.00 | Discretionary |
| May 26, 2009 | FACT | $0 | Award | 2,500 | $N/A | Discretionary |
| Jan 23, 2009 | FACT | $0 | Award | 8,333 | $N/A | Discretionary |